{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T07:52:17Z","timestamp":1680681137091},"reference-count":22,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2020]]},"DOI":"10.2152\/jmi.67.328","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T22:07:39Z","timestamp":1604527659000},"page":"328-331","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between oral condition and risk factors for jaw osteonecrosis in patients with hip fractures"],"prefix":"10.2152","volume":"67","author":[{"given":"Norio","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Sukegawa","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital, Kagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Sukegawa-Takahashi","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital, Kagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Kagawa Prefectural Central Hospital, Kagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Furuki","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital, Kagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ohta H, Mouri M, Kuroda T, Nakamura T, Shiraki M, Orimo H\u2005:\u2005Decreased rate of hip fracture and consequent reduction in estimated medical costs in Japan. J Bone Miner Metab 35\u2005:\u2005351-353, 2017","DOI":"10.1007\/s00774-016-0760-0"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kim YK, Yi SR, Lee YH, Kwon J, Jang SI, Park SH\u2005:\u2005Effect of sarcopenia on postoperative mortality in osteoporotic hip fracture patients. J Bone Metab 25\u2005:\u2005227-233, 2018","DOI":"10.11005\/jbm.2018.25.4.227"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lyles KW, Col\u00f3n-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, the HORIZON Recurrent Fracture Trial\u2005:\u2005Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357\u2005:\u20051799-1809, 2007","DOI":"10.1056\/NEJMoa074941"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Khan AZ, Rames RD, Miller AN\u2005:\u2005Clinical management of osteoporotic fractures. Curr Osteoporos Rep 16\u2005:\u2005299-311, 2018","DOI":"10.1007\/s11914-018-0443-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sukegawa S, Kanno T, Kawai H, Nakamura S, Shibata A, Sukegawa-Takahashi Y, Nagatsuka H, Furuki Y\u2005:\u2005A clinical retrospective study of surgical treatment for medication-related osteonecrosis of the jaw. J Hard Tissue Biol 25\u2005:\u2005447-454, 2016","DOI":"10.2485\/jhtb.25.447"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sukegawa S, Kanno T, Katase N, Matsuzaki H, Shibata A, Takahashi Y, Furuki Y\u2005:\u2005A massive osteonecrosis with Le Fort I-type pathological fracture, caused by bisphosphonate-related osteonecrosis of the jaw (BRONJ)\u2005:\u2005A rare case report. J Oral Maxillofac Surg Med Pathol 28\u2005:\u2005255-258, 2016","DOI":"10.1016\/j.ajoms.2015.10.001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Qi WX, Tang LN, He AN, Yao Y, Shen Z\u2005:\u2005Risk of osteonecrosis of the jaw in cancer patients receiving denosumab\u2005:\u2005a meta-analysis of seven randomized controlled trials. Int J Clin Oncol 19\u2005:\u2005403-410, 2014","DOI":"10.1007\/s10147-013-0561-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O\u2019Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Dabagh RA, Davison KS, Kendler DL, S\u00e1ndor GK, Josse RG, Bhandari M, Rabbany ME, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, International Task Force on Osteonecrosis of the Jaw\u2005:\u2005Diagnosis and management of osteonecrosis of the jaw\u2005:\u2005a systematic review and international consensus. J Bone Miner Res 30\u2005:\u20053-23, 2015","DOI":"10.1002\/jbmr.2405"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F, American Association of Oral and Maxillofacial Surgeons\u2005:\u2005American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg 72\u2005:\u20051938-1956, 2014","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"10","unstructured":"10. World Health Organization\u2005:\u2005Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 405\u2005:\u20055-37, 1968"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. The International Expert Committee\u2005:\u2005International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32\u2005:\u20051327-1334, 2009","DOI":"10.2337\/dc09-9033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Leslie WD, Adler RA, El-Hajj Fuleihan G, Hodsman AB, Kendler DL, McClung M, Miller PD, Watts NB, International Society for Clinical Densitometry\u2005:\u2005Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women\u2005:\u2005the 2005 ISCD Official Positions. J Clin Densitom 9\u2005:\u200522-30, 2006","DOI":"10.1016\/j.jocd.2006.05.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Bawa HS, Weick J, Dirschl DR\u2005:\u2005Anti-osteoporotic therapy after fragility fracture lowers rate of subsequent fracture. J Bone Joint Surg Am 97\u2005:\u20051555-1562, 2015","DOI":"10.2106\/JBJS.N.01275"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, Ohta H, Yoneda T, Tomomitsu T, Japanese Society for Bone and Mineral Research and Japan Osteoporosis Society Joint Review Committee for the Revision of the Diagnostic Criteria for Primary Osteoporosis\u2005:\u2005Diagnostic criteria for primary osteoporosis\u2005:\u2005year 2012 revision. J Bone Miner Metab 31\u2005:\u2005247-257, 2013","DOI":"10.1007\/s00774-013-0447-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Marx RE\u2005:\u2005Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws\u2005:\u2005a growing epidemic. J Oral Maxillofac Surg 61\u2005:\u20051115-1117, 2003","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL\u2005:\u2005Osteonecrosis of the jaws associated with the use of bisphosphonates\u2005:\u2005a review of 63 cases.\u201d J Oral Maxillofac Surg 62\u2005:\u2005527-534, 2004","DOI":"10.1016\/j.joms.2004.02.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Papapoulos S, Chapurlat R, Libanati C, Brandi ML, Brown JP, Czerwi\u0144ski E, Krieg MA, Man Z, Mellstr\u00f6m D, Radominski SC, Reginster JY, Resch H, Ivorra JAR, Roux C, Vittinghoff E, Austin M, Daizadeh N, Bradley MN, Grauer A, Cummings SR, Bone HG\u2005:\u2005Five years of denosumab exposure in women with postmenopausal osteoporosis\u2005:\u2005results from the first two years of the FREEDOM extension. J Bone Miner Res 27\u2005:\u2005694-701, 2012","DOI":"10.1002\/jbmr.1479"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kajizono M, Sada H, Sugiura Y, Soga Y, Kitamura Y, Matsuoka J, Sendo T\u2005:\u2005Incidence and risk factors of osteonecrosis of the jaw in advanced cancer patients after treatment with zoledronic acid or denosumab\u2005:\u2005a retrospective cohort study. Biol Pharm Bull 38\u2005:\u20051850-1855, 2015","DOI":"10.1248\/bpb.b15-00385"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD\u2005:\u2005Longitudinal alveolar bone loss in postmenopausal osteoporotic\u2009\/\u2009osteopenic women. Osteoporos Int 10\u2005:\u200534-40, 1999","DOI":"10.1007\/s001980050191"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tezal M, Wactawski-Wende J, Grossi SG, Ho AW, Dunford R, Genco RJ\u2005:\u2005The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 71\u2005:\u20051492-1498, 2000","DOI":"10.1902\/jop.2000.71.9.1492"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kudo Y, Tada H, Fujiwara N, Tada Y, Tsunematsu T, Miyake Y, Ishimaru N\u2005:\u2005Oral environment and cancer. Genes Environ 38\u2005:\u200513, 2016","DOI":"10.1186\/s41021-016-0042-z"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O\u2005:\u2005Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 10\u2005:\u2005CD012432, 2017","DOI":"10.1002\/14651858.CD012432.pub2"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/67\/3.4\/67_328\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:42:01Z","timestamp":1623112921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/67\/3.4\/67_328\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":22,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.67.328","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}